Treatment-response data further support the involvement of MMPs in psoriasis pathogenesis: in patients receiving anti-TNF-α therapy, reductions in MMP-9 levels were observed in PBMCs, serum, and skin, paralleling clinical improvement [41]. The gene discussed is MMP9; the disease is psoriasis.